Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. (Q31370338)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

1 July 2017

3 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

PubMed

https://github.com/jmillanacosta/retractable/blob/e28dcac33244e89948fe17fb65f09b59e2ed804d/data/PMIDS_DOIS.csv

title

Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. (English)

1 reference

G protein-coupled receptor

1 July 2017

main subject

0 references

1 reference

Xu Y

1 reference

1 July 2017

Zhu K

1 reference

1 July 2017

Hong G

1 reference

1 July 2017

Wu W

1 reference

1 July 2017

Baudhuin LM

1 reference

1 July 2017

Xiao Y

1 reference

1 July 2017

Damron DS

1 reference

1 July 2017

publication date

1 May 2000

1 reference

1 July 2017

1 reference

1 July 2017

1 reference

1 July 2017

1 reference

1 July 2017

page(s)

261-267

1 reference

Sphingolipid metabolites: members of a new class of lipid second messengers

1 July 2017

cites work

1 reference

7 January 2021

Sphingosylphosphorylcholine is a remarkably potent mitogen for a variety of cell lines

1 reference

7 January 2021

Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions

1 reference

7 January 2021

Sphingosylphosphorylcholine stimulates proliferation and upregulates cell surface-associated plasminogen activator activity in cultured human keratinocytes

1 reference

7 January 2021

Lysophospholipids activate ovarian and breast cancer cells

1 reference

7 January 2021

Modulation of T-lymphocyte proliferation by exogenous natural ceramides and sphingosylphosphorylcholine

1 reference

7 January 2021

Sphingosylphosphorylcholine induces a hypertrophic growth response through the mitogen-activated protein kinase signaling cascade in rat neonatal cardiac myocytes

1 reference

7 January 2021

A new wound healing agent--sphingosylphosphorylcholine

1 reference

7 January 2021

Sphingosylphosphorylcholine rapidly induces tyrosine phosphorylation of p125FAK and paxillin, rearrangement of the actin cytoskeleton and focal contact assembly. Requirement of p21rho in the signaling pathway

1 reference

7 January 2021

Sphingosylphosphorylcholine Activation of Mitogen-activated Protein Kinase in Swiss 3T3 Cells Requires Protein Kinase C and a Pertussis Toxin-sensitive G Protein

1 reference

7 January 2021

Pertussis toxin inhibits phospholipase C activation and Ca2+ mobilization by sphingosylphosphorylcholine and galactosylsphingosine in HL60 leukemia cells. Implications of GTP-binding protein-coupled receptors for lysosphingolipids

1 reference

7 January 2021

Effect of lysophospholipids on signaling in the human Jurkat T cell line

1 reference

7 January 2021

Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1

1 reference

7 January 2021

Sphingosylphosphorylcholine is a potent inducer of intercellular adhesion molecule-1 expression in human keratinocytes

1 reference

7 January 2021

Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex

1 reference

7 January 2021

Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids

1 reference

7 January 2021

Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1

1 reference

7 January 2021

Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid

1 reference

7 January 2021

EDG6, a novel G-protein-coupled receptor related to receptors for bioactive lysophospholipids, is specifically expressed in lymphoid tissue

1 reference

7 January 2021

Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5

1 reference

7 January 2021

Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins

1 reference

7 January 2021

EDG3 is a functional receptor specific for sphingosine 1-phosphate and sphingosylphosphorylcholine with signaling characteristics distinct from EDG1 and AGR16

1 reference

7 January 2021

EDG1 is a functional sphingosine-1-phosphate receptor that is linked via a Gi/o to multiple signaling pathways, including phospholipase C activation, Ca2+ mobilization, Ras-mitogen-activated protein kinase activation, and adenylate cyclase inhibitio

1 reference

7 January 2021

Activation of phospholipase C-Ca2+ system by sphingosine 1-phosphate in CHO cells transfected with Edg-3, a putative lipid receptor

1 reference

7 January 2021

Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218

1 reference

7 January 2021

Ligand-induced trafficking of the sphingosine-1-phosphate receptor EDG-1

1 reference

7 January 2021

Discrimination between plasma membrane and intracellular target sites of sphingosylphosphorylcholine

1 reference

7 January 2021

Identification of human OGR1, a novel G protein-coupled receptor that maps to chromosome 14

1 reference

7 January 2021

Phosphorylation of the inhibitory guanine-nucleotide-binding protein as a possible mechanism of inhibition by protein kinase C of agonist-induced Ca2+ mobilization in human platelet

1 reference

7 January 2021

Inhibition of MAP Kinase Kinase Blocks the Differentiation of PC-12 Cells Induced by Nerve Growth Factor

1 reference

7 January 2021

G protein-coupled receptors

1 reference

7 January 2021

Distinct pathways of Gi- and Gq-mediated mitogen-activated protein kinase activation

1 reference

7 January 2021

Activation of the mitogen-activated protein kinase cascade by pertussis toxin-sensitive and -insensitive pathways in cultured ventricular cardiomyocytes

1 reference

7 January 2021

Ca2+ dependent purinergic regulation of p42 and p44 MAP kinases in astroglial cultured cells

1 reference

7 January 2021

1 reference

7 January 2021

Okadaic acid activates p42 mitogen-activated protein kinase (MAP kinase; ERK-2) in B-lymphocytes but inhibits rather than augments cellular proliferation: contrast with phorbol 12-myristate 13-acetate

1 reference

7 January 2021

Role of mitogen-activated protein kinases in activation-induced apoptosis of T cells

1 reference

7 January 2021

The extracellular signal-regulated kinase pathway is required for activation-induced cell death of T cells

1 reference

7 January 2021

Lysosphingolipids and mitochondrial function. II. Deleterious effects of sphingosylphosphorylcholine.

1 reference

7 January 2021

Sphingosylphosphorylcholine in Niemann-Pick disease brain: accumulation in type A but not in type B.

1 reference

7 January 2021

Abnormal expression of sphingomyelin acylase in atopic dermatitis: an etiologic factor for ceramide deficiency?

1 reference

7 January 2021

Metabolism and neurite promoting effect of exogenous sphingosylphosphocholine in cultured murine neuroblastoma cells

1 reference

7 January 2021

Phenylephrine-induced Ca2+ oscillations in canine pulmonary artery smooth muscle cells

1 reference

7 January 2021

Modulation of smooth muscle contraction by sphingosylphosphorylcholine

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1038/35010529

Identifiers

DOI

10.1038/35010529

1 reference

Dimensions Publication ID

1 July 2017

1045739628

0 references

1 reference